Cargando…

An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral

Galidesivir (BCX4430) is an adenosine nucleoside analog that is broadly active in cell culture against several RNA viruses of various families. This activity has also been shown in animal models of viral disease associated with Ebola, Marburg, yellow fever, Zika, and Rift Valley fever viruses. In ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Julander, Justin G., Demarest, James F., Taylor, Ray, Gowen, Brian B., Walling, Dennis M., Mathis, Amanda, Babu, Y.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483777/ https://www.ncbi.nlm.nih.gov/pubmed/34551346 http://dx.doi.org/10.1016/j.antiviral.2021.105180

Ejemplares similares

BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
por: Taylor, Raymond, et al.
Publicado: (2016)

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
por: Warren, Travis K., et al.
Publicado: (2014)

Activity of Galidesivir in a Hamster Model of SARS-CoV-2
por: Taylor, Ray, et al.
Publicado: (2021)

Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus
por: Lim, So-Yon, et al.
Publicado: (2017)

Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys
por: Warren, Travis, et al.
Publicado: (2017)

Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
por: Westover, Jonna B., et al.
Publicado: (2018)

Broad-Spectrum Antivirals and Antiviral Combinations: An Editorial Update
por: Kainov, Denis, et al.
Publicado: (2022)

Arbidol as a broad-spectrum antiviral: An update
por: Blaising, Julie, et al.
Publicado: (2014)

Model-independent confirmation of the $Z(4430)^-$ state
por: Aaij, Roel, et al.
Publicado: (2015)

Observation of the resonant character of the $Z(4430)^-$ state
por: Aaij, Roel, et al.
Publicado: (2014)

Confirmation of the exotic $Z(4430)^±$ resonance at LHCb
por: Cowan, Greig
Publicado: (2014)

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011)

Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)

Modified cyclodextrins as broad-spectrum antivirals
por: Jones, Samuel T., et al.
Publicado: (2020)

Confirmation of the Z(4430)- resonance and other exotic meson results from the LHCb experiment
por: Cowan, Greig
Publicado: (2014)

Broad-spectrum antivirals against viral fusion
por: Vigant, Frederic, et al.
Publicado: (2015)

Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
por: Geraghty, Robert J., et al.
Publicado: (2021)

dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)

Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies
por: Soto-Acosta, Ruben, et al.
Publicado: (2021)

Exotic charmonium-like spectroscopy at LHCb : a study of the $X(3872)$ and of the $Z(4430)^-$ states
por: Pepe-Altarelli, Monica
Publicado: (2014)

Exotic charmonium-like spectroscopy at LHCb: a study of the X(3872) and of the Z(4430) $^-$ states
por: Pepe Altarelli, Monica
Publicado: (2014)

Molecular Characterization and Identification of Calnexin 1 As a Radiation Biomarker from Tradescantia BNL4430
por: Ha, Hye-Jeong, et al.
Publicado: (2020)

The broad-spectrum antiviral functions of IFIT and IFITM proteins
por: Diamond, Michael S., et al.
Publicado: (2012)

Drug repurposing for new, efficient, broad spectrum antivirals
por: García-Serradilla, Moisés, et al.
Publicado: (2019)

Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses
por: Ekins, Sean, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Broad-Spectrum Antivirals Derived from Natural Products
por: Tian, Wen-Jun, et al.
Publicado: (2023)

Near-Infrared Dyes: Towards Broad-Spectrum Antivirals
por: Mariewskaya, Kseniya A., et al.
Publicado: (2022)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021)

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
por: Safronetz, David, et al.
Publicado: (2015)

The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition
por: Goodier, John L., et al.
Publicado: (2015)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine
por: De Clercq, Erik, et al.
Publicado: (1990)

Nitazoxanide: A first-in-class broad-spectrum antiviral agent
por: Rossignol, Jean-François
Publicado: (2014)

Novel activities of safe-in-human broad-spectrum antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2018)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_flietl7jlkbe8uc4obphnmh6p8